Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
06/29/1989 | WO1989005815A1 Amino anthracenediones-bis platinum complexes, useful as antitumoral agents |
06/29/1989 | WO1989005649A1 Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
06/29/1989 | WO1989005648A1 Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof |
06/29/1989 | WO1989005647A1 Treatment of malignant tumors with 8-aminoadenosine 3',5'-cyclic phosphate and combinations of 8-aminoadenosine 3',5'-cyclic phosphate and 8-chloroadenosine 3',5'-cyclic phosphate |
06/29/1989 | WO1989005646A1 Uses of sulphated sugars |
06/29/1989 | WO1989005645A1 Use of sucralfate |
06/29/1989 | WO1989005637A1 Improving toxicity profiles in chemotherapy |
06/29/1989 | WO1989005631A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine |
06/28/1989 | EP0322262A1 Basic protein phospholipase A2 of an Elapide snake venom, amino acid sequence thereof, derivatives and fragments thereof, process for obtaining them, therapeutic compositions and diagnostic agents containing them |
06/28/1989 | EP0322198A2 Pheophorbide derivatives |
06/28/1989 | EP0322184A2 N-(2-Alkyl-3-mercapto-1,5-di-oxoalkyl)glycinamide derivatives and their use as collagenase inhibitors |
06/28/1989 | EP0321548A1 Novel amphiphilic nucleic acid conjugates |
06/27/1989 | US4843161 Platinum-intercalative complexes for the treatment of cancer |
06/27/1989 | US4843069 Anticancer agents |
06/27/1989 | CA1256378A1 Pharmaceutical composition containing at least one naphtalenic derivative as active principle |
06/21/1989 | EP0321122A2 Water soluble camptothecin analogs |
06/21/1989 | EP0320988A2 Epipodophyllotoxin glucoside 4'-acyl derivative |
06/21/1989 | EP0320960A1 Amino anthracenediones-bis platinum complexes, useful as antitumoral agents |
06/21/1989 | EP0320807A2 Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
06/21/1989 | EP0320528A1 Use of hemocyanins and arylphorins for influencing the immune system and the treatment of tumors |
06/20/1989 | US4841077 Isoflavone derivatives, and salts thereof, and cancerocidal and immunosuppressive agents containing the same |
06/20/1989 | US4840943 Androst-4-ene-3,17-diones and process for their preparation |
06/20/1989 | US4840938 Pharmaceutical compositions containing anthracycline glycosides |
06/20/1989 | CA1256114A1 Polycyclic compounds, their preparation and formulations containing them |
06/20/1989 | CA1256112A1 Imidazolyl, triazolyl, and tetrazolyl compounds |
06/20/1989 | CA1256026A1 Gamma interferon--interleukin-2 synergism |
06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
06/15/1989 | WO1989005307A1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen |
06/15/1989 | WO1989005159A1 Ultrasonic or shock wave operating process and agent for implementing said process |
06/15/1989 | WO1989005155A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells |
06/15/1989 | WO1989005149A1 Methyl cellulose pharmaceutical composition |
06/14/1989 | EP0320455A1 Araliphatyl aminoalcane diphosphonic acids |
06/14/1989 | EP0320437A2 17-Methylene and 17-ethylidene estratrienes having an oestrogenic activity |
06/14/1989 | EP0320433A2 Process using ultrasonic or shock waves, and means for carrying it out |
06/14/1989 | EP0320267A2 Glycoprotein growth modulation materials |
06/14/1989 | EP0320118A2 Peptides with collagenase inhibiting activity |
06/14/1989 | EP0319559A1 Novel heparin derivatives |
06/13/1989 | US4839370 Novel derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dione |
06/13/1989 | US4839348 Hypotensive agents; anticoagulants, antiischemic agents |
06/13/1989 | US4839346 Antitumor anthracycline glycosides, intermediates thereof, and composition and use thereof |
06/13/1989 | US4839155 Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy |
06/13/1989 | CA1255654A1 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use |
06/07/1989 | EP0319329A2 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment |
06/07/1989 | EP0319228A2 Novel compounds |
06/07/1989 | EP0319012A2 Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension |
06/07/1989 | EP0318948A2 Cleavable immunoconjugates for the delivery and release of agents in native form |
06/07/1989 | EP0318906A1 Lyophilized preparation of platinum compound |
06/07/1989 | EP0318902A2 Use of linear annelated tricyclics as inhibitors of erythrocyte aggregation |
06/07/1989 | CN1033277A Substituted tetralins, chromans and related compounds in treatment of asthma |
06/06/1989 | US4837221 Administering porphyrin derivative to locate tumor, illuminating with light |
06/06/1989 | US4837149 Fermentation of streptomyces with specific amino acids, adding cyanide salt |
06/06/1989 | US4837023 Compositions containing hexadecylophosphocholine and alkylglycerols and uses thereof |
06/06/1989 | US4837003 Radiolabeled antibody fragments |
06/06/1989 | CA1255300A1 Method of inducing immunosuppression |
06/01/1989 | WO1989004872A1 Immunoreactive heterochain antibodies |
06/01/1989 | WO1989004839A1 Improved ricin molecules and ricin toxin conjugates |
06/01/1989 | WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier |
06/01/1989 | WO1989004666A1 Treatment of cancer with somatostatin and analogs thereof |
06/01/1989 | DE3835962A1 Polyisodiaminocarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel und pflanzenschutzmittel Polyisodiaminocarbonsaeuren, process for their production and those containing medicinal and plant protection products |
05/31/1989 | EP0318464A2 Antitumor platinum complexes |
05/31/1989 | EP0318392A1 N-(vinblastinoyl-23)derivatives of 1-amino methylphosphonic acids, processes for their preparation and pharmaceutical compositions containing them |
05/31/1989 | EP0318302A1 Proteinaceous compositions |
05/31/1989 | EP0318225A2 6-Aryl aminomethyl quinoline derivatives and their use as anti-tumour agents |
05/31/1989 | EP0317957A2 Drug-monoclonal antibody conjugates |
05/31/1989 | EP0317956A2 Anti-tumor prodrugs |
05/31/1989 | CN1033183A Fluorocytidine derivatives |
05/30/1989 | US4835287 Antibiotic substance |
05/30/1989 | US4835281 S-alkylation of 2-guanidino-thiazol-4-yl-methanethiol |
05/30/1989 | US4835183 Method of treating cancerous and precancerous conditions |
05/30/1989 | US4835182 Enhancing drug delivery to the brain |
05/30/1989 | US4835176 Glycookadaic acid, preparation thereof and use thereof |
05/30/1989 | CA1254892C Substituted 7-oxomitosanes |
05/30/1989 | CA1254889A1 Cosmetic compositions containing 1,8-dihydroxy-10- phenyl-9-anthrone as an active ingredient; application thereof and process for preparing the active ingredient |
05/30/1989 | CA1254831A1 Combination modality cancer therapy |
05/24/1989 | EP0317505A1 Azacycloalkylalkandiphosphonic acids |
05/24/1989 | EP0317416A1 Process for the preparation of 1-chloro-5-alkyl isoquinolines condensed with aromatic groups, the products so obtained and their use as medicines |
05/24/1989 | EP0317401A1 Pharmaceutical composition for parenteral administration of navelbine |
05/24/1989 | EP0317281A2 Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them |
05/24/1989 | EP0317141A2 Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
05/24/1989 | EP0316967A1 Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same |
05/24/1989 | EP0316882A2 Monoclonal antibody recognizing alpha 2-- 3 bonds |
05/24/1989 | EP0316852A2 Inhibitors of nonenzymatic cross-linking |
05/24/1989 | EP0316657A1 Substituted quinazolinones as anticancer agents |
05/24/1989 | EP0316408A1 Method of tumor inhibition in warm-blooded animals |
05/23/1989 | US4833257 Compositions of matter and methods of using same |
05/23/1989 | US4833241 Anthracycline compound |
05/23/1989 | US4833240 Skin disorders; antiinflammatory agents; antialllergens; antitumor agents; ophthalmology |
05/23/1989 | US4833131 Anticarcinogenic agents |
05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
05/23/1989 | CA1254569A1 Sulfonic acid salts of 6-amino-1,5-dihydro-4h- imidazo¬4,5-c|pyridin-4-one |
05/23/1989 | CA1254557A1 (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides |
05/23/1989 | CA1254517A1 Pharmaceutical compositions containing 1,8-dihydroxy-10-phenyl-9-anthrone as an active ingredient |
05/23/1989 | CA1254514A1 Method for promoting nerve regeneration |
05/18/1989 | WO1989004312A1 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells |
05/18/1989 | WO1989004307A1 Substituted quinazolinones as anticancer agents |
05/18/1989 | WO1989004306A1 Fused pyridazine compounds and their medicinal uses |
05/18/1989 | WO1989004178A1 New therapeutical use of h2-receptor-blocking compounds |
05/18/1989 | WO1989004176A1 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
05/18/1989 | WO1989004168A1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
05/17/1989 | EP0316030A1 Vincristine-containing product |